Evidence map›Paper›PMID 34069184›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Risk Factors for Amoxicillin-Clavulanate Resistance in Community-Onset Urinary Tract Infections Caused by

Javier Martínez-Casanova, Silvia Gómez-Zorrilla, Nuria Prim, Agustina Dal Molin, Daniel Echeverría-Esnal, María Pilar Gracia-Arnillas, Elena Sendra, Robert Güerri-Fernández, Xavier Durán-Jordà, Eduardo Padilla and 3 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. High prevalence ofApplied and environmental microbiology · 2025
    Article
  2. Article
  3. Epidemiological, Virulence, and Antibiotic Resistance Analysis ofAnimals : an open access journal from MDPI · 2024
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Javier Martínez-CasanovaInfectious Pathology and Antimicrobials Research Group (IPAR), Pharmacy Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain.
Silvia Gómez-ZorrillaInfectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain.ORCID 0000-0002-5987-068X
Nuria PrimMicrobiology Service, Infectious Pathology and Antimicrobials Research Group (IPAR), Laboratoi de Referència de Catalunya, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain.
Agustina Dal MolinInfectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain.
Daniel Echeverría-EsnalInfectious Pathology and Antimicrobials Research Group (IPAR), Pharmacy Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain.ORCID 0000-0003-4975-8798
María Pilar Gracia-ArnillasCritical Care Department, GREPAC, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain.
Elena SendraInfectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain.ORCID 0000-0002-4374-2173
Robert Güerri-FernándezInfectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain.
Xavier Durán-JordàScientific, Statistics and Technical Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain.
Eduardo PadillaMicrobiology Service, Infectious Pathology and Antimicrobials Research Group (IPAR), Laboratoi de Referència de Catalunya, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain.
Juan Pablo HorcajadaInfectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain.
Santiago GrauInfectious Pathology and Antimicrobials Research Group (IPAR), Pharmacy Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain.ORCID 0000-0002-8428-1836
On Behalf Of The Proa-Psmar Group
Universitat Autònoma de Barcelona · ESMunicipal Institute for Medical Research · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh rates of amoxicillin-clavulanate (AMC) resistance among Enterobacterales isolated from urinary tract infections (UTIs) were observed in our area. The aim of this study was to identify risk factors associated with AMC resistance in patients with community-onset UTI in emergency departments (EDs).

methodsA retrospective study was performed of all ED patients with positive urine cultures for

results330 urine cultures in all were included: 261 (79.1%) for

conclusionsPrior antibiotic exposure, particularly to AMC or fluoroquinolones, was the only independent risk factor associated with development of AMC resistance in

Indexed as

amoxicillin/clavulanateantimicrobial resistanceemergency departmentEnterobacteralesfluoroquinolonesurinary tract infection (UTI)

Identifiers

PMID34069184
PMCPMC8156637
OpenAlexW3162367560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.